-+ 0.00%
-+ 0.00%
-+ 0.00%

Quoin Pharmaceuticals Holds Special Shareholder Meeting

PUBT·11/12/2026 22:20:26
Listen to the news
Quoin Pharmaceuticals Holds Special Shareholder Meeting
  • Quoin Pharmaceuticals shareholders approved amendments to investor beneficial ownership limits at a special general meeting on November 12, 2026.
  • The amendments permit affected private placement investors, upon written notice, to raise their ownership limits from 4.99% to no more than 9.99%.
  • Shareholders also authorized adjournment to a later date, if needed, to solicit further proxies supporting the ownership-limit amendments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-126328), on November 12, 2026, and is solely responsible for the information contained therein.